QQ客服 官方微博 反馈留言

	Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy
	Fan, Yang; Wang, Qingjie; Lin, Guimei; Shi, Yanbin; Gu, Zili; Ding, Tingting
刊名	ACTA BIOMATERIALIA
	2017
卷号	62页码:257-272
关键词	Co-delivery of GEM and DTX CD44-oriented tumor targeting Prodrug-modified liposome nanocomplexes Triple-negative breast cancer Potentiating effect
DOI	10.1016/j.actbio.2017.08.034
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4590403
专题	山东大学
作者单位	1.Shandong Univ, Sch Pharmaceut Sci, 44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China. 2.[Wan
推荐引用方式 GB/T 7714	Fan, Yang,Wang, Qingjie,Lin, Guimei,et al. Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy[J]. ACTA BIOMATERIALIA,2017,62:257-272.
APA	Fan, Yang,Wang, Qingjie,Lin, Guimei,Shi, Yanbin,Gu, Zili,&Ding, Tingting.(2017).Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy.ACTA BIOMATERIALIA,62,257-272.
MLA	Fan, Yang,et al."Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy".ACTA BIOMATERIALIA 62(2017):257-272.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。